1. Home
  2. ELTX vs MAIA Comparison

ELTX vs MAIA Comparison

Compare ELTX & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • MAIA
  • Stock Information
  • Founded
  • ELTX 2011
  • MAIA 2018
  • Country
  • ELTX United States
  • MAIA United States
  • Employees
  • ELTX N/A
  • MAIA N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • MAIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELTX Health Care
  • MAIA Health Care
  • Exchange
  • ELTX Nasdaq
  • MAIA Nasdaq
  • Market Cap
  • ELTX 49.7M
  • MAIA 62.4M
  • IPO Year
  • ELTX 2021
  • MAIA 2022
  • Fundamental
  • Price
  • ELTX $4.16
  • MAIA $2.82
  • Analyst Decision
  • ELTX Buy
  • MAIA
  • Analyst Count
  • ELTX 2
  • MAIA 0
  • Target Price
  • ELTX $10.00
  • MAIA N/A
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • MAIA 60.0K
  • Earning Date
  • ELTX 11-07-2024
  • MAIA 11-05-2024
  • Dividend Yield
  • ELTX N/A
  • MAIA N/A
  • EPS Growth
  • ELTX N/A
  • MAIA N/A
  • EPS
  • ELTX N/A
  • MAIA N/A
  • Revenue
  • ELTX N/A
  • MAIA N/A
  • Revenue This Year
  • ELTX N/A
  • MAIA N/A
  • Revenue Next Year
  • ELTX N/A
  • MAIA N/A
  • P/E Ratio
  • ELTX N/A
  • MAIA N/A
  • Revenue Growth
  • ELTX N/A
  • MAIA N/A
  • 52 Week Low
  • ELTX $2.96
  • MAIA $0.82
  • 52 Week High
  • ELTX $11.45
  • MAIA $5.99
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • MAIA 50.98
  • Support Level
  • ELTX $4.05
  • MAIA $2.36
  • Resistance Level
  • ELTX $4.89
  • MAIA $2.72
  • Average True Range (ATR)
  • ELTX 0.28
  • MAIA 0.22
  • MACD
  • ELTX -0.06
  • MAIA 0.02
  • Stochastic Oscillator
  • ELTX 27.37
  • MAIA 72.28

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Share on Social Networks: